senate Bill S4788A

2017-2018 Legislative Session

Relates to interchangeable biological products

download bill text pdf

Sponsored By

Current Bill Status Via A7509 - Passed Senate & Assembly


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

do you support this legislation?

You must fill out the form below in order to support or oppose this bill. X

You must login or fill out the fields below for the senator to have an accurate account of the support or opposition to this bill.

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.
Use this box to enter a message to your senator.

Actions

view actions (10)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jun 21, 2017 returned to assembly
passed senate
3rd reading cal.2161
substituted for s4788a
Jun 21, 2017 substituted by a7509a
ordered to third reading cal.2161
committee discharged and committed to rules
Jun 16, 2017 print number 4788a
amend (t) and recommit to higher education
Mar 01, 2017 referred to higher education

Co-Sponsors

view additional co-sponsors

S4788 - Details

See Assembly Version of this Bill:
A7509A
Law Section:
Education Law
Laws Affected:
Amd §§6802, 6810 & 6816-a, Ed L; amd §206, Pub Health L

S4788 - Summary

Relates to interchangeable biological products; enacts provisions relating to substitutions of biological products by pharmacists.

S4788 - Sponsor Memo

S4788 - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  4788

                       2017-2018 Regular Sessions

                            I N  S E N A T E

                              March 1, 2017
                               ___________

Introduced  by  Sen.  HANNON -- read twice and ordered printed, and when
  printed to be committed to the Committee on Higher Education

AN ACT to amend the education law and the public health law, in relation
  to  the  substitution  of  interchangeable  biological  products   for
  prescribed products

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 6802 of the education law is amended by adding  two
new subdivisions 27 and 28 to read as follows:
  27.  "BIOLOGICAL  PRODUCT"  MEANS  A  BIOLOGICAL PRODUCT AS DEFINED IN
SUBSECTION (I) OF SECTION 351 OF  THE  PUBLIC  HEALTH  SERVICE  ACT,  42
U.S.C. SECTION 262(I).
  28.  "INTERCHANGEABLE  BIOLOGICAL  PRODUCT" MEANS A BIOLOGICAL PRODUCT
LICENSED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION  PURSUANT  TO
42  U.S.C.    SECTION  262(K)(4)  AS  SET FORTH IN THE LATEST EDITION OR
SUPPLEMENT OF THE UNITED STATES FOOD AND DRUG  ADMINISTRATION  LISTS  OF
LICENSED  BIOLOGICAL  PRODUCTS  WITH  REFERENCE  PRODUCT EXCLUSIVITY AND
BIOSIMILARITY OR INTERCHANGEABILITY EVALUATIONS, SOMETIMES  REFERRED  TO
AS  THE  "PURPLE BOOK," OR A BIOLOGICAL PRODUCT DETERMINED BY THE UNITED
STATES FOOD AND DRUG ADMINISTRATION TO BE THERAPEUTICALLY EQUIVALENT  AS
SET  FORTH IN THE LATEST EDITION OR SUPPLEMENT OF THE UNITED STATES FOOD
AND DRUG ADMINISTRATION APPROVED DRUG PRODUCTS WITH  THERAPEUTIC  EQUIV-
ALENCE EVALUATIONS, SOMETIMES REFERRED TO AS THE "ORANGE BOOK."
  S  2.  Paragraphs (b), (c) and (d) of subdivision 6 of section 6810 of
the education law, paragraph (b) as amended and paragraph (d)  as  added
by  chapter  913  of the laws of 1986, paragraph (c) as added by chapter
776 of the laws of 1977, are amended to read as follows:
  (b) NOTWITHSTANDING ANY OTHER PROVISION OF THIS SECTION OR  ANY  OTHER
LAW, WHEN AN INTERCHANGEABLE BIOLOGICAL PRODUCT IS NOT AVAILABLE AND THE
BIOLOGICAL PRODUCT ORIGINALLY PRESCRIBED IS AVAILABLE AND THE PHARMACIST
AGREES  TO  DISPENSE  THE PRESCRIBED BIOLOGICAL PRODUCT FOR A PRICE THAT

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD02608-02-7

Co-Sponsors

view additional co-sponsors

S4788A (ACTIVE) - Details

See Assembly Version of this Bill:
A7509A
Law Section:
Education Law
Laws Affected:
Amd §§6802, 6810 & 6816-a, Ed L; amd §206, Pub Health L

S4788A (ACTIVE) - Summary

Relates to interchangeable biological products; enacts provisions relating to substitutions of biological products by pharmacists.

S4788A (ACTIVE) - Sponsor Memo

S4788A (ACTIVE) - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 4788--A

                       2017-2018 Regular Sessions

                            I N  S E N A T E

                              March 1, 2017
                               ___________

Introduced by Sens. HANNON, DeFRANCISCO, GRIFFO, HELMING, LATIMER, VALE-
  SKY  -- read twice and ordered printed, and when printed to be commit-
  ted to the Committee on Higher Education -- committee discharged, bill
  amended, ordered reprinted as amended and recommitted to said  commit-
  tee

AN ACT to amend the education law and the public health law, in relation
  to   the  substitution  of  interchangeable  biological  products  for
  prescribed  products;  and  providing  for  the  expiration  of   such
  provisions

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 6802 of the education law is amended by adding  two
new subdivisions 27 and 28 to read as follows:
  27.  "BIOLOGICAL  PRODUCT"  MEANS  A  BIOLOGICAL PRODUCT AS DEFINED IN
SUBSECTION (I) OF SECTION 351 OF  THE  PUBLIC  HEALTH  SERVICE  ACT,  42
U.S.C. SECTION 262(I).
  28.  "INTERCHANGEABLE  BIOLOGICAL  PRODUCT" MEANS A BIOLOGICAL PRODUCT
LICENSED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION  PURSUANT  TO
42  U.S.C.    SECTION  262(K)(4)  AS  SET FORTH IN THE LATEST EDITION OR
SUPPLEMENT OF THE UNITED STATES FOOD AND DRUG  ADMINISTRATION  LISTS  OF
LICENSED  BIOLOGICAL  PRODUCTS  WITH  REFERENCE  PRODUCT EXCLUSIVITY AND
BIOSIMILARITY OR INTERCHANGEABILITY EVALUATIONS, SOMETIMES  REFERRED  TO
AS  THE  "PURPLE BOOK," OR A BIOLOGICAL PRODUCT DETERMINED BY THE UNITED
STATES FOOD AND DRUG ADMINISTRATION TO BE THERAPEUTICALLY EQUIVALENT  AS
SET  FORTH IN THE LATEST EDITION OR SUPPLEMENT OF THE UNITED STATES FOOD
AND DRUG ADMINISTRATION APPROVED DRUG PRODUCTS WITH  THERAPEUTIC  EQUIV-
ALENCE EVALUATIONS, SOMETIMES REFERRED TO AS THE "ORANGE BOOK."
  S  2.  Paragraphs (b), (c) and (d) of subdivision 6 of section 6810 of
the education law, paragraph (b) as amended and paragraph (d)  as  added
by  chapter  913  of the laws of 1986, paragraph (c) as added by chapter
776 of the laws of 1977, are amended to read as follows:

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD02608-03-7

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.